ESR1 and breast carcinoma: Since estrogen-independent ER signaling has been implicated in the development of resistance to adjuvant therapy, it was the goal of this study to examine the relationship between hormone-independent actions of ER and the basal cycling state of estrogen deprived breast cancer cells.